Tamarack Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Tamarack Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-110,000	Closed	-$14.8M	–	6
2015 Q3	$14.8M	Sell	110,000 -11,050	-9%	-$1.59M	1.76%	17
2015 Q2	$18.2M	Buy	121,050 +13,050	+12%	+$1.87M	2.1%	15
2015 Q1	$14.6M	Buy	108,000 +3,000	+3%	+$372K	1.92%	19
2014 Q4	$12.7M	Buy	105,000 +21,622	+26%	+$2.49M	1.92%	18
2014 Q3	$9.46M	Buy	83,378 +67,009	+409%	+$7.94M	2.1%	18
2014 Q2	$1.93M	Buy	+16,369	New	+$2M	0.39%	27

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Tamarack Capital Management's BIO Position: Q4 2015 in Review

Tamarack Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2015, closing a stake of 110,000 shares — an estimated $14.8M sold.

Tamarack Capital Management first reported a position in BIO in Q2 2014 and held it in 6 quarters. The position peaked at $18.2M in Q2 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q4 2015.

Tamarack Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2015 after selling out during the quarter.
Tamarack Capital Management sold 110,000 Bio-Rad Laboratories Class A shares in Q4 2015, an estimated $14.8M.
Tamarack Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 6 quarters.
Tamarack Capital Management's Bio-Rad Laboratories Class A position peaked at $18.2M in Q2 2015.
241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2015.

Based on Tamarack Capital Management's 13F filing for Q4 2015.